Our research
Bowel cancer is the UK’s fourth most common cancer, and the second biggest cancer killer. Yet it doesn’t have to be this way. When diagnosed at the earliest stages, bowel cancer is treatable and curable.
Research strategy 2024-2030
Our roadmap for research: Driving early diagnosis and better outcomes for bowel cancer
We’re delighted to share our new research strategy, Our roadmap for research. Developed in consultation with patient representatives, clinicians and researchers, our research strategy sets out how we'll help improve early diagnosis and treatment of the disease through research.
Research is an incredibly powerful instrument of change. All the initiatives that currently benefit patients with bowel cancer — from diagnostics and surgical techniques through to personalised medicines and beyond — started life as research ideas that required careful nurturing, funding and development into the life-changing interventions we have today.
Our research strategy will support two of our strategic goals:
- Goal 1: Remove the barriers to people being diagnosed quickly, and at the earliest possible stage
- Goal 2: Get the right treatment and care to every patient
We’ll do this by funding research directly and bringing the research community together with patients, other funders and industry. Only through working collectively will real and lasting change happen, helping to create a future where nobody dies of bowel cancer.
